Selank Dosage: What the Evidence Says (2026)
Not FDA-approved
Tuftsin-analogue peptide used in Russia. Not FDA-approved and not compoundable in the US.
Also called: TP-7
Regulatory status (US)
Not approved by the FDA for any use. Its nomination for pharmacy compounding was withdrawn, so it is on none of FDA's 503A lists and is not covered by the October 2026 HHS draft policy. In practice that means no legal US source for human use.
What it is
A seven-amino-acid peptide built on tuftsin, an immune peptide.
Dosage
What human studies show
- Clinical studies are almost all Russian-language. There is no FDA-reviewed dosing.
Safety
- No established human dose under US review.
Questions
- Is Selank FDA-approved?
- Not approved by the FDA for any use. Its nomination for pharmacy compounding was withdrawn, so it is on none of FDA's 503A lists and is not covered by the October 2026 HHS draft policy. In practice that means no legal US source for human use.
- What dose of Selank has been studied?
- There is no established human dose. Clinical studies are almost all Russian-language. There is no FDA-reviewed dosing.
Related
The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.
BPC-15715-amino-acid peptide studied mostly in animals. Not approved; no established human dose.
TB-500 (thymosin beta-4)Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.
GHK-Cu (copper peptide)Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.
Sources
Last checked 2026-11-16. How we pick and check sources: methodology.